TOPLINE: While most potassium-competitive acid blockers demonstrate superior healing rates than proton pump inhibitors (PPIs) in patients with erosive esophagitis, both types of treatment offer relief […]

TOPLINE: Both chronic and new-onset anxiety are linked to a threefold increased risk for dementia onset in later life, new research shows. METHODOLOGY: A total of […]

TOPLINE: Breast cancer immunotherapy trials yield modest clinical impact, with a quarter of trials failing to report their outcomes, particularly among single-center studies which are more […]

TOPLINE: Elevated depression symptoms are linked to an increased risk for severe chemotherapy toxicity in older adults with cancer. This risk is mitigated by geriatric assessment […]

TOPLINE: The monoclonal antibody ofatumumab appears to be more effective in achieving a disease-free state in relapsing-remitting multiple sclerosis (RRMS) than the immunomodulatory drug teriflunomide, across […]

TOPLINE: Romosozumab leads to a greater increase in bone mineral density (BMD) than teriparatide in postmenopausal women, with lower discontinuation rates and fewer cardiovascular events. METHODOLOGY: […]